Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation. (Q44291981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

Monika Karczewska-Kupczewska

24 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Agnieszka Adamska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Agnieszka Nikolajuk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

E Otziomek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

I Kowalska

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

19 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1386-1390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2013.10

24 February 2020

exact match

0 references

cites work

FGF-21 as a novel metabolic regulator

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Skeletal muscle fat oxidation: timing and flexibility are everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

Insulin sensitivity, metabolic flexibility, and serum adiponectin concentration in women with anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.10

21 January 2018

Identifiers

DOI

10.1038/IJO.2013.10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419601%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference